Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acquisition Criteria Remain Conservative For Large Cardiovascular Firms

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific, Guidant and St. Jude Medical business development chiefs are reluctant to consider technologies outside their firms' core strengths when weighing potential acquisitions
Advertisement

Related Content

Split Rock Prepped To Invest In Medical Device Realm After Financing
Split Rock Prepped To Invest In Medical Device Realm After Financing
Can Cardio Firms Curb M&A? Selective Seeding Is Combo Product Strategy
Endosurgery, Vascular Growth Seeded By Boston Scientific; Grissom Hired
Endosurgery, Vascular Growth Seeded By Boston Scientific; Grissom Hired
Epicor AF Ablation Device Could Drive St. Jude Catheter, Valve Procedures
Advertisement
UsernamePublicRestriction

Register

MT020171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel